Five Prime Therapeutics
Patents, Design & Utilities
Last updated:
List of all Five Prime Therapeutics patents 48 in total
| Status | Patent |
|---|---|
Grant | Utility: FGFR2 inhibitors alone or in combination with immune stimulating agents in cancer treatment Filling date: 26 Sep 2025 Issue date: 20 Sep 2022 |
Grant | Utility: Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic cancer Filling date: 26 Sep 2025 Issue date: 23 Aug 2022 |
Grant | Utility: Antibodies binding to ILT4 Filling date: 26 Sep 2025 Issue date: 2 Aug 2022 |
Application | Utility: PHARMACEUTICAL FORMULATIONS CONTAINING CD80 EXTRACELLULAR DOMAIN-FC FUSION PROTEINS Filling date: 26 Sep 2025 Issue date: 21 Jul 2022 |
Application | Utility: Afucosylated Anti-FGFR2IIIB Antibodies Filling date: 26 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: Antibodies that Bind Colony Stimulating Factor 1 Receptor (CSF1R) Filling date: 26 Sep 2025 Issue date: 19 May 2022 |
Grant | Utility: B7-H4 antibodies and methods of use thereof Filling date: 26 Sep 2025 Issue date: 19 Apr 2022 |
Application | Utility: Antibodies Binding to Vista at Acidic pH Filling date: 26 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: Anti-FGFR2 Antibodies in Combination with Chemotherapy Agents in Cancer Treatment Filling date: 26 Sep 2025 Issue date: 10 Feb 2022 |
Grant | Utility: Afucosylated anti-FGFR2IIIB antibodies Filling date: 26 Sep 2025 Issue date: 1 Feb 2022 |
Application | Utility: Anti-FGFR2 Antibody Formulations Filling date: 26 Sep 2025 Issue date: 13 Jan 2022 |
Grant | Utility: Antibodies that bind colony stimulating factor 1 receptor (CSF1R) Filling date: 26 Sep 2025 Issue date: 30 Nov 2021 |
Application | Utility: CD80 EXTRACELLULAR DOMAIN FC FUSION PROTEIN DOSING REGIMENS Filling date: 26 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: COMBINATION THERAPY FOR CANCER Filling date: 26 Sep 2025 Issue date: 28 Oct 2021 |
Grant | Utility: Anti-ROR1 antibodies Filling date: 26 Sep 2025 Issue date: 26 Oct 2021 |
Application | Utility: Methods of Treating Conditions with Antibodies that Bind Colony Stimulating Factor 1 Receptor (CSF1R) Filling date: 26 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: Methods of Treating Conditions with Antibodies that Bind Colony Stimulating Factor 1 Receptor (CSF1R) Filling date: 26 Sep 2025 Issue date: 9 Sep 2021 |
Grant | Utility: CD80 extracellular domain polypeptides and their use in cancer treatment Filling date: 26 Sep 2025 Issue date: 24 Aug 2021 |
Grant | Utility: Method of treating gastric cancer with anti-FGFR2-IIIb antibodies and modified FOLFOX6 chemotherapy Filling date: 26 Sep 2025 Issue date: 17 Aug 2021 |
Application | Utility: ENHANCED CYTOMETRY FOR TISSUE CHARACTERIZATION AND SCREENING Filling date: 26 Sep 2025 Issue date: 15 Jul 2021 |
Grant | Utility: Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R) Filling date: 26 Sep 2025 Issue date: 20 Apr 2021 |
Application | Utility: Methods of Treating Conditions with Antibodies that Bind Colony Stimulating Factor 1 Receptor (CSF1R) Filling date: 26 Sep 2025 Issue date: 15 Apr 2021 |
Grant | Utility: Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R) Filling date: 26 Sep 2025 Issue date: 13 Apr 2021 |
Application | Utility: B7-H4 ANTIBODIES AND METHODS AND USE THEREOF Filling date: 26 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: B7-H4 ANTIBODY DOSING REGIMENS Filling date: 26 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: B7-H4 ANTIBODY FORMULATIONS Filling date: 26 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: Antibodies Binding to Vista at Acidic pH Filling date: 26 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: Anti-CSF1R Antibodies for Treating PVNS Filling date: 26 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: Combination Anti-CSF1R and Anti-PD-1 Antibody Combination Therapy for Pancreatic Cancer Filling date: 26 Sep 2025 Issue date: 14 Jan 2021 |
Grant | Utility: Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R) Filling date: 26 Sep 2025 Issue date: 3 Nov 2020 |
Grant | Utility: NOPE for treatment of pathological muscle loss and weakness Filling date: 26 Sep 2025 Issue date: 13 Oct 2020 |
Application | Utility: Anti-CSF1R Antibody and Anti-PD-1 Antibody Combination Therapy for Cancer Filling date: 26 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: B7-H4 ANTIBODIES AND METHODS OF USE THEREOF Filling date: 26 Sep 2025 Issue date: 13 Aug 2020 |
Grant | Utility: Method of treating PVNS with anti-CSF1R antibodies Filling date: 26 Sep 2025 Issue date: 4 Aug 2020 |
Application | Utility: Combination Therapy for Cancer Filling date: 26 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: Antibodies that Bind Colony Stimulating Factor 1 Receptor (CSF1R) Filling date: 26 Sep 2025 Issue date: 16 Jul 2020 |
Application | Utility: METHODS OF TREATMENT WITH CD80 EXTRACELLULAR DOMAIN POLYPEPTIDES Filling date: 26 Sep 2025 Issue date: 11 Jun 2020 |
Grant | Utility: Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer Filling date: 26 Sep 2025 Issue date: 14 Apr 2020 |
Application | Utility: Antibodies Binding to ILT4 Filling date: 26 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: Anti-FGFR2 Antibodies in Combination with Chemotherapy Agents in Cancer Treatment Filling date: 26 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: Antibodies Binding to VISTA at Acidic pH Filling date: 26 Sep 2025 Issue date: 20 Feb 2020 |
Grant | Utility: Antibodies that bind colony stimulating factor 1 receptor (CSF1R) Filling date: 26 Sep 2025 Issue date: 18 Feb 2020 |
Application | Utility: COMBINATION THERAPY FOR CANCER USING ANTI-GITR ANTIBODIES Filling date: 26 Sep 2025 Issue date: 30 Jan 2020 |
Grant | Utility: Methods of treating lung cancer Filling date: 26 Sep 2025 Issue date: 21 Jan 2020 |
Application | Utility: MEDICAL USE OF INTERFERON-LAMBDA FOR THE TREATMENT OF FIBROSIS Filling date: 26 Sep 2025 Issue date: 12 Dec 2019 |
Application | Utility: PSGL-1 Antagonists and Uses Thereof Filling date: 26 Sep 2025 Issue date: 31 Oct 2019 |
Application | Utility: COMBINED ANTI TUMOR THERAPY WITH A GITR AGONIST AND CPG Filling date: 26 Sep 2025 Issue date: 29 Aug 2019 |
Application | Utility: Methods of Treating Conditions with Antibodies that Bind Colony Stimulating Factor 1 Receptor (CSF1R) Filling date: 26 Sep 2025 Issue date: 15 Aug 2019 |
Showing 1 to 48 of 48 patents.